The Impact of Interventional Enzymes on Post-Operative Wound Healing - A Double-Blinded Randomized Clinical Trial. - NA

Advanced Vital Enzymes P. Ltd. (Advenza)0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Patients with 25-50 years of age (both inclusive);
•2.Patients electively posted for clean surgery (Dental surgery, Orthopaedic surgery, Cosmetic Surgery, Laparoscopic, etc.) will be included in the study;
•3.Patient without any suspected or confirmed infection and receiving treatment for same;
•4.Willing to give informed consent for the study.

•1.Allergy, sensitivity, or contraindication to any interventional product;
•2.Patients undergoing emergency, clean – contaminated, contaminated and dirty surgical procedure cases;
•3.Patient with hepatic and/or renal disorder, bleeding disorders, menorrhagia, hematuria and hematemesis;
•4.History of gastric ulcer or bleeding diathesis;
•5.Currently receiving cytotoxic therapy, or have received it within the last three months;
•6.Patients treated with any investigational drug in the preceding 4 weeks;
•7.Female patients with a positive pregnancy test or lactating;
•8.Patients with uncontrolled diabetes mellitus or any other metabolic disorder;
•9.Seriously ill and moribund patients with complications;
•10.Patients unable to comply with the treatment regimen;
•11.Patients with any other condition that, in the opinion of the investigator, does not justify the inclusion of the patient in the study.

发起方

Advanced Vital Enzymes P. Ltd. (Advenza)